Skip to main content
Analysts Hike Target Prices For Piramal Enterprises After Carlyle Deal - BloombergQuint 30-Jun-2020
Analysts Hike Target Prices For Piramal Enterprises After Carlyle Deal - BloombergQuint
Carlyle Group will pay about $490 million for a 20% stake in Piramal Pharma at an enterprise valuation of $2,775 million.
More...